North China Pharmaceutical Company. Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 8,638.322 million compared to CNY 8,026.052 million a year ago. Operating income was CNY 172.859 million compared to CNY 139.327 million a year ago. Net income was CNY 128.088 million compared to CNY 91.529 million a year ago. Basic earnings per share from continuing operations was CNY 0.079 compared to CNY 0.056 a year ago.